• Users Online: 85
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2016  |  Volume : 1  |  Issue : 4  |  Page : 17-22

Seroprevalence of hepatitis B and C Virus Infections among type 2 diabetic patients in a tertiary care diabetic centre in Dhaka City


Department of gastrointestinal, hepatobiliary and pancreatic disorders (GHPD), BIRDEM General Hospital, Dhaka, Bangladesh

Correspondence Address:
Md Golam Azam
Department of gastrointestinal, hepatobiliary and pancreatic disorders (GHPD), BIRDEM General Hospital, Dhaka
Bangladesh
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Aims: This study was carried out to explore the prevalence of HBV and HCV infections among type 2 diabetes mellitus (T2DM) patients and risk factors. This cross-sectional study was conducted at BIRDEM General Hospital, Dhaka, Bangladesh between January 2012 and March 2013. Subjects and Methods: A total of 1024 type 2 diabetics were included. Well-structured questionnaire was used to collect demographic profile and history of the study populations. Venous blood samples were collected to screen HBV, HCV infections and to estimate other biochemical tests. Data analysis was carried out using SPSS version 16.0. Descriptive analysis was performed and results expressed as means±SD and n (%). P <0.05 was considered significant. Results: Prevalence of HBV in type 2 diabetics was 3.0% (31/1024) and HCV was 0.48% (5/1024). Among all subjects, mean±SD of body mass index (BMI) was 24.9±3.8, fasting blood sugar mmol/L was 10.7±4.6, post prandial blood sugar mmol/L was 17.6±7.2, fasting cholesterol mg/dl was 198.5±81.3, haemoglobin gm/dl was 13.1±1.5, serum ALT IU/L was 40.5±36.0. Mean serum ALT was significantly higher among HBV-positive T2DM participants (57.7 IU/L) than HBV-negative participants (36.2 IU/L) (P=0.001). Conclusions: The seroprevalence of HBV was higher than that of HCV in T2DM patients. T2DM patients should take necessary preventive measures like prophylactic vaccination to reduce the risk of HBV infection and its consequences.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed508    
    Printed60    
    Emailed0    
    PDF Downloaded78    
    Comments [Add]    

Recommend this journal